Healthline
April 5, 2025
Share on PinterestThe FDA recently authorized a new at-home test for common sexually transmitted infections that can be purchased without a prescription. simonkr/Getty Images The FDA […]
April 5, 2025
Share on PinterestVal Kilmer’s death highlights the serious risks of pneumonia, especially for older adults and those with a history of illness. Stephane Cardinale/Corbis via Getty […]
April 4, 2025
Share on PinterestDefunding Planned Parenthood could limit health services provided by the organization, most impacting lower-income households and people in rural areas. Kayla Bartkowski/Getty Images The […]
April 3, 2025
Share on PinterestThe FDA’s new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. […]
Medscape
April 4, 2025
In women with signs of ischemia but no obstructive coronary artery disease (OCAD), intensive medical therapy did not reduce the first occurrence of a major cardiovascular […]
April 4, 2025
The US Food and Drug Administration (FDA) has approved the B-cell depleting agent inebilizumab-cdon (Uplizna, Amgen) for the treatment of immunoglobulin G4-related disease (IgG4-RD). This is […]
April 4, 2025
Efforts by the government and NHS England (NHSE) to improve NHS dental access have “comprehensively failed,” according to a damning report from the Commons Public Accounts […]
April 4, 2025
NEW ORLEANS — For people with type 2 diabetes (T2D) inadequately controlled on submaximal dulaglutide (Trulicity) doses, switching to tirzepatide (Mounjaro) produces significantly greater A1c and […]
FDA
April 1, 2025
This web page provides information about the in vitro susceptibility of fungi to certain drugs. The safety and efficacy of these drugs in treating clinical infections due […]
March 31, 2025
Alecensa (alectinib) capsules Alunbrig (brigatinib) tablets Lorbrena (lorlatinib) tablets Zykadia (ceritinib) capsules; tablets Optic neuropathy FDA is evaluating the need for regulatory action. Antidepressants Selective serotonin […]
March 31, 2025
Delivery Method: VIA Electronic Mail Product: Drugs Recipient: Recipient Name Mr. Mingzhong Su Recipient Title President Sani-Care Salon Products, Inc. 51 Curtis Court, Ste. BCartersville, GA […]
March 28, 2025
On March 28, 2025, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent durvalumab as […]
